Plasma cell-free DNA chromatin immunoprecipitation profiling depicts phenotypic and clinical heterogeneity in advanced prostate cancer.
Sipola J, Munzur AD, Kwan EM, Seo CCY, Hauk BJ, Parekh K, Liao YJR, Bernales CQ, Donnellan G, Bloise I, Fung E, Ng SWS, Wang G, Vandekerkhove G, Nykter M, Annala M, Maurice-Dror C, Chi KN, Herberts C, Wyatt AW, Takeda DY.
Sipola J, et al. Among authors: seo ccy.
Cancer Res. 2024 Dec 9. doi: 10.1158/0008-5472.CAN-24-2052. Online ahead of print.
Cancer Res. 2024.
PMID: 39652574